Case Study
Learn more about KLEPTOSE® BioPharma for your protein stability challenges
![Learn more about KLEPTOSE® BioPharma for your protein stability challenges](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/pharmaceutical-science/biopharma-reporter.com/library/learn-more-about-kleptose-r-biopharma-for-your-protein-stability-challenges/9546437-1-eng-GB/Learn-more-about-KLEPTOSE-R-BioPharma-for-your-protein-stability-challenges.png)
Therapeutic proteins are inherently unstable and sensitive to temperature change, shearing, shaking, solvents, ionic strength, purity, protein concentration, pressure and freeze/thaw-drying cycles. Read our latest research in this case study to learn more about how Roquette’s KLEPTOSE® BioPharma (hydroxypropyl beta cyclodextrin) represents a promising alternative to surfactants commonly used within biologic formulations, such as polysorbates Tween 20 and 80.